Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression

Association between Immunosuppressive Therapy Utilized in the Treatment of Autoimmune Disease or Transplant and Cancer Progression

Autoimmunity and cancer rates have both been on the rise in Western civilization prompting many to investigate the link between the two entities. This review will investigate the complex interactions between the activation and deactivation of the immune system and the development of malignancy. Addi...

Full description

Bibliographic Details
Main Authors:	Amanda Reyes, Atish Mohanty, Rebecca Pharaon, Erminia Massarelli
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Biomedicines
Subjects:	autoimmunity immunodeficiency immunosurveillance TNF-alpha inhibitors calcineurin inhibitors mTOR inhibitors
Online Access:	https://www.mdpi.com/2227-9059/11/1/99

Similar Items

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
by: Cosmin Tegla, et al.
Published: (2020-01-01)

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
by: Pil Soo Sung, et al.
Published: (2021-07-01)

Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes
by: J Kumar, et al.
Published: (2017-04-01)

Effects of Antirejection Drugs on Innate Immune Cells After Kidney Transplantation
by: Gianluigi Zaza, et al.
Published: (2019-12-01)

Non-melanoma skin cancer outcomes in kidney transplant recipients converted from calcineurin inhibitors to mTOR inhibitors: a systematic review
by: Berenika Olszewska, et al.
Published: (2023-06-01)

Overview of Research into mTOR Inhibitors
by: Beibei Mao, et al.
Published: (2022-08-01)

Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant Centers
by: Cornelius Engelmann, et al.
Published: (2020-07-01)

Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01)

RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
by: Ahlem Jebali, et al.
Published: (2021-10-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

Incidence of Cytomegalovirus disease in kidney transplant recipients receiving Everolimus and reduced Tacrolimus doses: A cohort retrospective analysis
by: Juliana Bastos, et al.
Published: (2021-10-01)

The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma
by: Letizia Todeschini, et al.
Published: (2023-06-01)

Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols
by: Indranil Ghosh, et al.
Published: (2016-01-01)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
by: Wojciech Wiese, et al.
Published: (2023-11-01)

Conversion to everolimus to preserve kidney function in a heart transplant recipient, a personalized approach of immunos uppressive therapy
by: N. N. Koloskova, et al.
Published: (2018-09-01)

Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy
by: Abdelhakim Bouyahya, et al.
Published: (2022-11-01)

The Role of mTOR in B Cell Lymphoid Malignancies: Biologic and Therapeutic Aspects
by: Eleni A. Karatrasoglou, et al.
Published: (2023-09-01)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)

Immunosuppression with Calcineurin Inhibitor after Renal Transplant Failure Inhibits Allosensitization
by: Covadonga López del Moral Cuesta, et al.
Published: (2020-03-01)

Therapeutic Approach to Post-Transplant Recurrence of Hepatocellular Carcinoma: Certainties and Open Issues
by: Giuseppe Marrone, et al.
Published: (2023-11-01)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01)

Kaposi’s sarcoma regression after long term treatment of m-TOR inhibitors and cancellation of immunosuppressive therapy in patient after kidney transplantation
by: A. D. Sapozhnikov, et al.
Published: (2019-07-01)

Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study
by: Rabea Asleh, et al.
Published: (2022-01-01)

ACUTE TACROLIMUS-INDUCED KIDNEY INSUFFICIENCY IN PATIENT AFTER HEART TRANSPLANTATION
by: D. V. Doronin, et al.
Published: (2016-04-01)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)

mTOR Signaling Pathway in Cancer Targets Photodynamic Therapy In Vitro
by: Sandra M. Ayuk, et al.
Published: (2019-05-01)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
by: Won Seop Kim
Published: (2011-06-01)

Early use of everolimus improved renal function after adult deceased donor liver transplantation
by: Seohee Lee, et al.
Published: (2021-03-01)

EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
by: E. I. Prokopenko
Published: (2010-06-01)

Impact of tacrolimus versus cyclosporine on one-year renal transplant outcomes : a single-centre retrospective cohort study
by: Ong, Pei Wen, et al.
Published: (2021)

Assessment of Renal Transplant Perfusion by Contrast-Enhanced Ultrasound after Switch from Calcineurin Inhibitor to Belatacept: A Pilot Study
by: Bilgin Osmanodja, et al.
Published: (2022-07-01)

Hepatic epithelioid hemangioendothelioma successfully treated with living donor liver transplantation: A case report and literature review
by: Sotaro Fukuhara, et al.
Published: (2020-01-01)

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study
by: Carla Vela, et al.
Published: (2022-12-01)

Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
by: Eui Joo Kim, et al.
Published: (2020-11-01)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
by: Zhilin Zou, et al.
Published: (2020-03-01)

Asymptomatic Pulmonary Tuberculosis in a Child under TNF-alpha Inhibitor Therapy
by: Manolya Acar, et al.
Published: (2017-03-01)

Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma
by: Hung Huynh, et al.
Published: (2023-12-01)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
by: Kirby Sean, et al.
Published: (2012-03-01)

Posttransplantation Hypomagnesemia as a Predictor of Better Graft Function after Transplantation
by: Tammy Hod, et al.
Published: (2020-11-01)

Oral ulcerations in an immunosuppressed pediatric patient
by: Ansley DeVore, MD, et al.
Published: (2023-12-01)